Ali Mirazimi
Adjunct Professor
E-mail: ali.mirazimi@ki.se
Visiting address: Nobels väg 7, 17165 Solna
Postal address: H5 Laboratoriemedicin, H5 Klin Mikrobiologi Mirazimi, 141 52 Huddinge
About me
- Adjunct Professor, Karolinska Institute
Head of Section, Swedish veterinary Institute
Senior Expert Scintist, Public Health Agency of Sweden
Research
- Viral Zoonosis, Virus-Host interaction, Diagnostic, Vaccine and Antivioral development
Articles
- Article: NATURE MICROBIOLOGY. 2024;9(5):1499-1512
- Article: ANTIVIRAL RESEARCH. 2024;225:105844
- Article: JOURNAL OF GENERAL VIROLOGY. 2024;105(4):001974
- Article: MOLECULAR THERAPY. 2024;32(2):540-555
- Article: MICROORGANISMS. 2024;12(3):443
- Article: NATURE COMMUNICATIONS. 2023;14(1):6785
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(37):e2304722120
- Article: JOURNAL OF GENERAL VIROLOGY. 2023;104(8):001864
- Article: VACCINE. 2023;41(32):4743-4751
- Article: LIFE SCIENCE ALLIANCE. 2023;6(7):e202302005
- Article: MOLECULAR THERAPY. 2023;31(2):387-397
- Article: NATURE COMMUNICATIONS. 2022;13(1):7926
- Article: STAR PROTOCOLS. 2022;3(4):101872
- Article: ARCHIVES OF VIROLOGY. 2022;167(12):2857-2906
- Article: EMBO MOLECULAR MEDICINE. 2022;14(10):e15821
- Article: EMBO MOLECULAR MEDICINE. 2022;14(8):e15230
- Article: CELL METABOLISM. 2022;34(6):857-873.e9
- Article: PATHOGENS. 2022;11(5):602
- Article: JOURNAL OF GENERAL VIROLOGY. 2022;103(4)
- Article: JOURNAL OF VIROLOGY. 2022;96(3):e0156821-e01521
- Article: ANTIVIRAL RESEARCH. 2022;198:105251
- Article: ELIFE. 2021;10:e73641
- Article: CELL GENOMICS. 2021;1(3):100065
- Article: ARCHIVES OF VIROLOGY. 2021;166(12):3513-3566
- Article: JOURNAL OF VIROLOGY. 2021;95(24):e0163821-10.1128/jvi.01621
- Article: VETERINARY MEDICINE AND SCIENCE. 2021;7(6):2323-2329
- Article: EMBO JOURNAL. 2021;40(19):e108375
- Article: MICROORGANISMS. 2021;9(8):1731
- Article: PATHOGENS. 2021;10(8):1025
- Article: CELL STEM CELL. 2021;28(8):1362-1379.e7
- Article: VIRUSES-BASEL. 2021;13(7):1250
- Article: BIOTECHNOLOGY JOURNAL. 2021;16(6):e2000566
- Article: ISCIENCE. 2021;24(5):102420
- Article: SCIENTIFIC REPORTS. 2021;11(1):10617
- Article: CELL DEATH DISCOVERY. 2021;7(1):114
- Article: JOURNAL OF VIROLOGICAL METHODS. 2021;290:114075
- Article: VIRUSES-BASEL. 2021;13(3):372
- Article: NATURE MICROBIOLOGY. 2021;6(2):187-195
- Article: EMBO MOLECULAR MEDICINE. 2021;13(1):e13426
- Article: SCIENCE ADVANCES. 2021;7(1):eabe4724
- Article: VIRUSES-BASEL. 2020;13(1):E37-37
- Article: VIRUSES-BASEL. 2020;12(12):E1423-1423
- Article: MICROORGANISMS. 2020;8(12):E1927-1927
- Article: ARCHIVES OF VIROLOGY. 2020;165(12):3023-3072
- Article: EMERGING MICROBES & INFECTIONS. 2020;9(1):1748-1760
- Article: MICROORGANISMS. 2020;8(12):E1890-1890
- Article: PLOS NEGLECTED TROPICAL DISEASES. 2020;14(11):e0008863
- Article: LANCET RESPIRATORY MEDICINE. 2020;8(11):1154-1158
- Article: JOURNAL OF VIROLOGICAL METHODS. 2020;284:113941
- Article: PLOS NEGLECTED TROPICAL DISEASES. 2020;14(9):e0008610
- Article: EMBO MOLECULAR MEDICINE. 2020;12(8):e12697
- Article: JOURNAL OF GENERAL VIROLOGY. 2020;101(8):798-799
- Article: EUROSURVEILLANCE. 2020;25(28):2000291-28
- Article: TICKS AND TICK-BORNE DISEASES. 2020;11(4):101417
- Article: CELL. 2020;181(4):905-913.e7
- Article: JOURNAL OF MOLECULAR DIAGNOSTICS. 2020;22(2):272-283
- Article: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2020;18:3734-3744
- Article: FRONTIERS IN MEDICINE. 2020;7:225
- Article: INFECTIOUS DISEASE CLINICS OF NORTH AMERICA. 2019;33(4):977-1002
- Article: VIRUSES-BASEL. 2019;11(10):953
- Article: ARCHIVES OF VIROLOGY. 2019;164(7):1949-1965
- Article: EMERGING INFECTIOUS DISEASES. 2019;25(5):955-957
- Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2018;15(12):2775
- Article: BIOSCIENCE REPORTS. 2018;38(5):bsr20181059
- Article: ANTIVIRAL RESEARCH. 2018;158:127-134
- Article: PLOS NEGLECTED TROPICAL DISEASES. 2018;12(7):e0006598
- Article: CLINICAL MICROBIOLOGY AND INFECTION. 2018;24(6):653-657
- Article: JOURNAL OF VIROLOGICAL METHODS. 2018;255:38-43
- Article: JOURNAL OF VIROLOGICAL METHODS. 2018;252:70-74
- Article: ANTIVIRAL RESEARCH. 2018;150:137-147
- Article: JOURNAL OF VIROLOGY. 2017;91(10):10.1128/jvi.02076-10.1128/jvi.02016
- Article: JOURNAL OF VIROLOGICAL METHODS. 2017;242:35-45
- Article: FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 2017;5:98
- Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2016;54(10):2521-2529
- Article: FEMS MICROBIOLOGY LETTERS. 2016;363(8):fnw058
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2016;291(2):582-592
- Article: EUROSURVEILLANCE. 2015;20(44):10-18
- Article: ANALYTICAL CHEMISTRY. 2015;87(16):8394-8398
- Article: ANTIVIRAL RESEARCH. 2015;120:57-65
- Article: PATHOGENS AND DISEASE. 2015;73(5):ftv032
- Article: JOURNAL OF VIROLOGY. 2015;89(11):5957-5967
- Article: JOURNAL OF MEDICAL VIROLOGY. 2015;87(4):686-693
- Article: JOURNAL OF GENERAL VIROLOGY. 2015;96(Pt 3):538-546
- Article: JOURNAL OF CLINICAL VIROLOGY. 2015;64:137-143
- Article: VECTOR-BORNE AND ZOONOTIC DISEASES. 2014;14(12):870-872
- Article: EMERGING INFECTIOUS DISEASES. 2014;20(2):288-290
- Article: PLOS ONE. 2014;9(6):e100813
- Article: EMERGING INFECTIOUS DISEASES. 2012;18(12):1958-1965
- Article: JOURNAL OF VIROLOGY. 2012;86(22):12294-12303
- Article: VACCINE. 2012;30(44):6225-6229
- Article: VIROLOGY. 2012;426(2):87-92
- Article: PLOS NEGLECTED TROPICAL DISEASES. 2012;6(6):e1706
- Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2011;49(12):4279-4285
- Article: JOURNAL OF VIROLOGY. 2011;85(15):7766-7774
- Article: VIROLOGY JOURNAL. 2011;8:81
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2011;286(5):3227-3234
- Article: MICROBES AND INFECTION. 2011;13(2):179-188
- Article: JOURNAL OF VIROLOGY. 2010;84(16):8275-8286
- Article: JOURNAL OF GENERAL VIROLOGY. 2010;91(Pt 6):1473-1477
- Journal article: OPEN VIROLOGY JOURNAL. 2010;4(2):38-41
- Article: OPEN VIROLOGY JOURNAL. 2010;4:38-41
- Article: JOURNAL OF MEDICAL VIROLOGY. 2010;82(3):467-475
- Article: JOURNAL OF GENERAL VIROLOGY. 2010;91(Pt 1):199-207
- Article: VIROLOGY. 2009;395(1):1-9
- Article: VIROLOGY. 2009;390(2):157-162
- Article: EUROSURVEILLANCE. 2009;14(12):11-14
- Article: VIROLOGY. 2009;385(2):313-322
- Article: JOURNAL OF GENERAL VIROLOGY. 2009;90(Pt 1):210-215
- Article: JOURNAL OF MEDICAL VIROLOGY. 2008;80(8):1397-1404
- Article: PLOS ONE. 2008;3(4):e2032
- Journal article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2007;29:s281
- Article: JOURNAL OF VIROLOGY. 2007;81(5):2158-2164
- Article: ANTIVIRAL RESEARCH. 2007;73(3):219-227
- Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2006;36(10):2649-2657
- Article: VIRUS RESEARCH. 2006;120(1-2):184-190
- Article: FEBS LETTERS. 2006;580(16):3799-3803
- Article: JOURNAL OF MEDICAL VIROLOGY. 2006;78(2):216-222
- Article: JOURNAL OF VIROLOGY. 2005;79(3):1966-1969
- Article: JOURNAL OF MEDICAL VIROLOGY. 2004;73(3):404-411
- Article: JOURNAL OF VIROLOGY. 2004;78(8):4323-4329
- Article: JOURNAL OF MEDICAL VIROLOGY. 2004;72(1):83-93
- Article: JOURNAL OF GENERAL VIROLOGY. 2003;84(Pt 4):875-883
- Article: JOURNAL OF VIROLOGY. 2000;74(17):8048-8052
- Article: JOURNAL OF GENERAL VIROLOGY. 1999;80:2861-2865
- Article: JOURNAL OF CONTROLLED RELEASE. 1999;59(3):377-389
- Article: JOURNAL OF VIROLOGY. 1998;72(11):8705-8709
- Article: JOURNAL OF VIROLOGY. 1998;72(5):3887-3892
- Article: VIROLOGY. 1996;217(2):554-563
- Show more
All other publications
- Conference publication: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2023;130:s10-s11
- Corrigendum: NATURE COMMUNICATIONS. 2023;14(1):1142
- Conference publication: MOLECULAR THERAPY. 2023;31(4):358-359
- Letter: CELL. 2022;185(11):1837-1839
- Preprint: BIORXIV. 2022
- Review: PATHOGENS. 2022;11(2):271
- Preprint: BIORXIV. 2021
- Corrigendum: ARCHIVES OF VIROLOGY. 2021;166(12):3567-3579
- Editorial comment: ACTA PAEDIATRICA. 2021;110(10):2810-2811
- Preprint: BIORXIV. 2021;BIORXIV
- Preprint: BIORXIV. 2021
- Preprint: RESEARCH SQUARE. 2021
- Preprint: BIORXIV. 2021
- Book chapter: ENCYCLOPEDIA OF VIROLOGY. 2021;p. 208-217
- Letter: JOURNAL OF VIROLOGY. 2020;94(18):e01279-e01220
- Conference publication: 2020;:122
- Preprint: RESEARCH SQUARE. 2020
- Conference publication: MOLECULAR THERAPY. 2020;28(4):61
- Other: ARCHIVES OF VIROLOGY. 2019;164(3):927-941
- Review: EUROSURVEILLANCE. 2019;24(5):1800093-19
- Letter: EMERGING MICROBES & INFECTIONS. 2018;7(1):190-5
- Review: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2017;7:213
- Review: JOURNAL OF GENERAL VIROLOGY. 2016;97(11):2799-2808
- Letter: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(1):280-281
- Review: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):227-237
- Conference publication: JOURNAL OF CLINICAL VIROLOGY. 2015;70:s13
- Conference publication: MOLECULAR BIOLOGY OF THE CELL. 2015;26
- Book chapter: WORKING IN BIOSAFETY LEVEL 3 AND 4 LABORATORIES. 2013;p. 5-12
- Editorial comment: PLOS PATHOGENS. 2013;9(1):e1003105
- Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2012;16:e51
- Book chapter: BSL3 AND BSL4 AGENTS. 2012;p. 253-289
- Book chapter: BSL3 AND BSL4 AGENTS. 2012;p. 350-360
- Conference publication: IMMUNOLOGY. 2012;137:636-637
- Meeting abstract: ANTIVIRAL RESEARCH. 2011;90(2):a59
- Review: FUTURE VIROLOGY. 2010;5(4):469-479
- Letter: EMERGING INFECTIOUS DISEASES. 2009;15(11):1858a-11860
- Letter: NATURE REVIEWS MICROBIOLOGY. 2009;7(10):756
- Review: CYTOKINE & GROWTH FACTOR REVIEWS. 2008;19(5-6):395-404
- Book chapter: CRIMEAN-CONGO HEMORRHAGIC FEVER. 2007;p. 245-269
- Doctoral thesis: 2000
- Show more
Grants
- CCHFVaCIM1 January 2024 - 31 January 2028
- COVID-19 Variant Supplement - Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)Canadian Institutes of Health Research1 March 2021 - 28 February 2022
- MADCOV2Innovative medicine initiative2 August 2020 - 30 April 2024
- Vienna Science and Technology Fund1 May 2020 - 30 April 2021
- Sex as a Biological Variable Supplement - Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)Canadian Institutes of Health Research1 May 2020 - 30 April 2021
- Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)Canadian Institutes of Health Research1 February 2020 - 31 January 2022
- Swedish Research Council1 December 2019 - 31 December 2022
- Swedish Research Council1 December 2018 - 31 December 2023
- Swedish Research Council1 January 2018 - 31 December 2020
- Swedish Research Council1 January 2018 - 31 December 2020
- CCHFVaccineHorizon 20201 January 2017 - 31 December 2024
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 January 2017 - 31 December 2019
- Swedish Research Council for Environment Agricultural Sciences and Spatial Planning1 January 2016 - 31 December 2018
- Infect-ERA utlysning 2014: Second multilateral call for research Projects of Infect-ERA. ESCential, Haploid embryonic stem cell screen to identify host factors essential for highly pathogenic RNA virSwedish Research Council1 December 2014 - 31 December 2016
- Swedish Research Council1 January 2010 - 31 December 2012
Employments
- Adjunct Professor, Department of Laboratory Medicine, Karolinska Institutet, 2015-2027
Degrees and Education
- Docent, Karolinska Institutet, 2006
- Doctor Of Philosophy, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2000